Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Other Accumulated Expenses (2024 - 2025)

Biofrontera (BFRI) has 2 years of Other Accumulated Expenses data on record, last reported at $681000.0 in Q3 2025.

  • For Q3 2025, Other Accumulated Expenses changed N/A year-over-year to $681000.0; the TTM value through Sep 2025 reached $681000.0, changed N/A, while the annual FY2024 figure was $671000.0, N/A changed from the prior year.
  • Other Accumulated Expenses reached $681000.0 in Q3 2025 per BFRI's latest filing, roughly flat from $683000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $683000.0 in Q2 2025 and bottomed at $600000.0 in Q1 2025.